Showing results (1081-1090 of 1,512) with videos related to
Sort By:
Pageof 152
Science Translational Medicine|December 9, 2016
AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastasesZhenfan Yang, Qiuli Guo, Yingchun Wang, et al.Kidney Research and Clinical Practice|June 20, 2020
The KNOW-CKD Study: What we have learned about chronic kidney diseasesKook-Hwan Oh, Minjung Kang, Eunjeong Kang, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 11, 2011
Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapyJin Won Kim, Yongjun Cha, Su-Jung Kim, et al.Experimental & Molecular Medicine|January 5, 2006
Radiosensitization by targeting radioresistance-related genes with protein kinase A inhibitor in radioresistant cancer cellsChur Chin, Jae Ho Bae, Mi Ju Kim, et al.The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|November 23, 2005
[Disintegration of pancreatic duct stones with extracorporeal shockwave lithotripsy]Kwi-Sook Choi, Myung-Hwan Kim, Yoon-Seon Lee, et al.Oncotarget|September 15, 2017
Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)Hye Ryun Kim, Joung Soon Jang, Jong-Mu Sun, et al.Journal of Gastroenterology and Hepatology|November 25, 2010
Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinomaHyoung-Chul Oh, Myung-Hwan Kim, Kyu Taek Lee, et al.Translational Stroke Research|February 10, 2023
Targeted Metabolomic Biomarkers for Stroke SubtypingEung-Joon Lee, Da Jung Kim, Dong-Wan Kang, et al.Yonsei Medical Journal|February 14, 2018
Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung CancerJaemin Jo, Se Hyun Kim, Yu Jung Kim, et al.Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapyJong Seok Lee, Ki Hyeong Lee, Eun Kyung Cho, et al.Pageof 152